Introduction

Thank you for attending the Fall 2020 CTN Meetings

This year, the CTN marks its 30th anniversary. Thank you for being a part of this journey, and from everyone at the National Centre, we were pleased to welcome you to the first virtual CTN fall meeting. COVID-19 has certainly changed the way we live our lives, and while we’re glad to have the tools to gather together online, we certainly miss the connections built when we gather in-person at our meetings. With these meetings, we support the latest in HIV research and share key learnings from our research cores.

Dr. Aslam Anis, CTN National Director

October 2020

Virtual Meetings Schedule

Monday, October 19 - Committee Meetings

7:00-10:00 AM PST / 10:00 AM-1:00 PM EST 

Community Advisory Committee Meeting

(Community Advisory Committee members only)

Click for meeting documents 

Tuesday, October 20 - Committee Meetings and Core Sessions

7:00-9:00 AM PST / 10:00 AM-12:00 PM EST 

Scientific Review Committee Meeting

(Scientific Review Committee members only)

Click for meeting documents 

9:15-10:00 AM PST / 12:15-1:00 PM EST

Official Welcome – CTN and C4 Updates

(Open to all CTN Investigators)

Click to join the session (Attendees only)

10:00-11:00 AM PST / 1:00-2:00 PM EST

CRC Core Session

(Open to all CTN Investigators)
  • 10:00-10:10 AM PST / 1:00-1:10 PM EST
    Welcome, Introduction from the CRC Co-Leads, and Research Update 
    Drs. Ann Burchell and Dr. Curtis Cooper
  • 10:10-10:50 AM PST / 1:10-1:50 PM EST
    Speaker (TOPIC: COVID-19 and HIV)
    Dr. Sharon Walmsley
  • 10:50 PST / 1:50 PM EST
    Q&A and Discussion 

Continuing Professional Development (CPD) Learning Objectives:

  1. List ongoing projects associated with the Co-infection and Related Conditions (CRC) Core.
  2. Identify potential new projects and priority areas to be explored by the CRC Core.
  3. Assess the current state of knowledge about HIV and COVID-19 and critique new and ongoing pre-clinical and clinical trials.

Click to join the session (Attendees only)

 

12:00-1:00 PM PST / 3:00-4:00 PM EST

VIT Core Session

(Open to all CTN Investigators)
  • 12:00-12:05 PM PST / 3:00-3:05 PM EST
    Welcome, Introduction by the VIT Co-Leads
    Drs. Mario Ostrowski and Jean-Pierre Routy

Project Updates + Q&A Period

  • 12:05-12:15 PM PST / 3:05 – 3:15 PM EST
    CTN PT 027: The Lilac Study
    Dr. Jean-Pierre Routy
  • 12:15-12:30 PM PST / 3:15-3:30 PM EST
    CTN PT 032: The Camu Camu Pilot Study & CTN PT 038: The Gutsy Study
    Dr. Stéphane Isnard
  • 12:30-12:40 PM PST / 3:30-3:40 PM EST
    Project Update Question & Answer Period
    Drs. Jean-Pierre Routy and Stéphane Isnard

Guest Speaker (20 minutes + 10-minute Q&A)

  • 12:40-1:10 PM PST / 3:40-4:10 EST
    Camu Camu in a mouse model of cancer: Relevance for HIV related inflammation
    Dr. Bertrand Routy
    CHUM; University of Montreal, Montreal

Closing Statements

  • 1:10 PM PST / 4:10 PM EST
    Drs. Mario Ostrowski and Jean-Pierre Routy

Continuing Professional Development (CPD) Learning Objectives – VIT Core Session:

  1. Relate gut health to HIV transmission and overall health.
  2. Explain how Camu Camu berry improves gut health and prevents inflammation in People living with HIV and other chronic diseases.
  3. Identify new targets for improving gut health as a way to reduce HIV reservoir size.

Click to join the session (Attendees only)

Wednesday, October 21 - Core Sessions and Postdoctoral Fellow Presentations

8:00-9:30 AM PST / 11:00 AM-12:30 PM EST 

CCM Core Session

(Open to all CTN Investigators)
  • 8:00-8:10 AM PST / 11:00-11:10 AM EST
    Welcome, Land Acknowledgement and Brief Introduction of Core Research Development Teams (RDTs), RDT Co-Chairs and New CCM Core Investigators
    Drs. Mona Loutfy and Jason Brophy

Project updates (10-minute presentation + 5-minute Q&A)

  • 8:10-8:25 AM PST / 11:10-11:25 AM EST
    Entering a new Era for those living and aging with HIV-how do we meet the last 90 of the UN AIDS goals for HIV? How CHANGEHIV (correlates of healthy aging in geriatric HIV) will help
    Dr. Sharon Walmsley and Andrew Eaton, MSW, PhD candidate
  • 8:25-8:40 AM PST / 11:25-11:40 AM EST
    Cardiovascular risks in the context of aging with HIV and update on CTN 272: Canadian HIV and Aging cohort
    Dr. Madeleine Durand
  • 8:40-8:55 AM PST / 11:40-11:55 AM EST
    Hormones and Healthy Aging for Women Living with HIV
    Dr. Melanie Murray
  • 8:55-9:10 AM PST / 11:55 AM-12:10 PM EST
    Cannabinoids and inflammaging in people living with HIV
    Drs. Cecilia Costiniuk and Ali Jenabian

Community Panel Discussion

  • 9:10-9:30 AM PST / 12:10-12:30 PM EST
    What does aging well with HIV mean?
    Should research focus efforts on harm or symptom reduction?
    Should research focus on ways to prevent co-morbidities and premature aging in the context of HIV?
    Muluba Habanyama, Darren Lauscher, and Guy-Henri Godin
  • 9:30 AM PST / 12:30 PM EST
    Closing Statements
    Drs. Mona Loutfy and Jason Brophy

Continuing Professional Development (CPD) Learning Objectives:

  1. List aspects of aging that are similar or exacerbated in the context of HIV including: biological, immune and psychosocial aspects of aging.
  2. Identify which standard treatments or best practices for supporting people as they age need to be altered in the context of aging with HIV.
  3. Identify aspects of aging with HIV that are inadequately treated and should be pursued as future research areas/interventions.
  4. Identify cardiovascular risks and signs of cardiovascular disease in people living and aging with HIV.
  5. Define inflammaging with respect to people aging with HIV.
  6. Explain the role of medical cannabis and other novel treatments in promoting healthy aging with HIV.

Click to join the session (Attendees only)

 

10:30-11:30 AM PST / 1:30-2:30 PM EST

Postdoctoral Fellow Presentations

(Open to all CTN Investigators)
  • Examining Loneliness and Social Support to Improve Safer Sexual Behaviour Among Gay, Bisexual, and other Men who have sex with Men.
    Shayna Skakoon-Sparling, PhD
    National Team Manager – Engage Study
    CTN/CIHR Postdoctoral Research Fellow – HIV Prevention Lab
    Psychology Department
    Ryerson University
  • GetCheckedOnline: An institutional ethnography of the adaptation and scale-up of internet-based testing for sexually transmitted and blood-borne infections.
    Oralia Gomez-Ramirez, PhD
    CTN Postdoctoral Research Fellow
    Online Sexual Health Services
    BC Centre for Disease Control
    School of Population and Public Health, University of British Columbia
  • Effects of Folate Deficient Diet on Fetal Development when Pregnant Mice are Exposed to Dolutegravir in Combination with Tenofovir and Emtricitabine.
    Haneesha Mohan, PhD
    CTN/CIHR Postdoctoral Fellow
    University Health Network (UHN)
    Toronto General Research Institute
    Princess Margaret Cancer Research Tower (PMCPT)
    University of Toronto
  • Exploring the Menopausal Experience in HIV
    Dr. Elizabeth King (Bagnall)
    CTN “Mark Wainberg” Postdoctoral Fellow
    Clinician Investigator Program fellow, MSFHR trainee
    CIHR Women’s Health Mentorship Grant
    Department of Medicine, Division of Infectious Diseases
    University of British Columbia

Click to join the session (Attendees only)

 

12:00-1:00 PM PST / 3:00-4:00 PM EST

Postdoctoral Fellow Presentations

(Open to all CTN Investigators)
  • The Camu Camu Study: Effects on circulating LPS and systemic immune activation in ART-treated participants (CTN PT 032) and The Gutsy Study: Fecal microbiota transplantation to reduce immune activation in HIV-infected ART-treated participants with low CD4 T-cell count (CTN PT 038)
    Stéphane Isnard, PhD
    CTN/FRQ-S Postdoctoral Fellow
    Research Institute of the McGill University Health Centre
    Infectious Disease and Immunity in Global Health Program
  • Action for Positive Brain Health Now: Ready, Set, Go
    Adria Quigley, PhD
    Gilead/CTN Postdoctoral Fellow
    Centre for Outcomes Research and Evaluation
    McGill University
  • Frequency and Quantity of Mucosal and Plasma CMV Detected in Ugandan Adults Living With and Without HIV
    Elizabeth McClymont, PhD
    CANFAR/CTN Postdoctoral Fellow
    Department of Obstetrics and Gynaecology, Montreal University
  • An Ontario CHIWOS Snapshot and the Women-Centred HIV Care Toolkit Pilot Study in the Martimes.
    Priscilla Medeiros, PhD
    CTN Postdoctoral Fellow
    Women’s College Research Institute
    Women’s College Hospital
    University of Toronto

Click to join the session (Attendees only)

Thursday, October 22 - Core Sessions and Committee Meetings

8:00-9:30 AM PST / 11:00 AM-12:30 PM EST

PREV Core Session

(Open to all CTN Investigators)
  • 8:00-8:10 AM PST / 11:00-11:10 AM EST
    Welcome, Introduction and Overview of Current PREV Core Studies from the PREV Co-Leads
    Drs. Darrell Tan and Trevor Hart

Research Presentations

  • 8:10-8:25 AM PST / 11:10-11:25 AM EST
    A) Drum & Sash
    Dr. Rachel Landy and Carrielynn Lund
  • 8:25-8:40 AM PST / 11:25-11:40 AM EST
    B) Crystal Meth Interventions: State of the research and work they are currently doing in Canada to understand crystal methamphetamine interventions
    Drs. Nathan Lachowsky and Kiffer Card
  • 8:40-9:05 AM PST / 11:40 AM-12:05 PM EST
    C) Engage Cohort Study: Using community-engaged research to design and implement a cohort study of gay, bisexual, and other men who have sex with men (MSM) to identify how biomedical HIV prevention is changing HIV and STI outcomes in Vancouver, Toronto, and Montreal
    Dr. Joe Cox 
  • 9:05-9:20 AM PST / 12:05-12:20 PM EST
    Breakout groups: Three groups led by their respective project leads
    A) Drum & Sash: Rachel Landy and Carrielynn Lund
    B) Crystal Meth Intervention: Nathan Lachowsky & Kiffer Card
    C) Engage Cohort Study: Joe Cox. Participants will choose to join a group based on their own interest to learn more about the project
  • 9:20-9:30 AM PST / 12:20-12:30 PM EST
    Summary of Lessons Learned from Breakout Session
    One representative summarizes discussion for each breakout group

Continuing Professional Development (CPD) Learning Objectives:

  1. Outline the ways the Drum & Sash project integrates holistic wellness and HIV prevention intervention model to Indigenous Peoples across Canada.
  2. Describe the relationship between crystal methamphetamine use and HIV risk. Explain strategies that can be taken to mitigate adverse health outcomes associated with crystal methamphetamine use.
  3. List high-risk behaviours for HIV transmission or acquisition in the MSM population based on lessons learned from the Engage Cohort Study.
  4. Identify patients who are at high-risk of HIV transmission or acquisition within their own practice.

Click to join the session (Attendees only)

10:30-11:30 AM PST / 1:30-2:30 PM EST

Steering Committee Meeting

(Steering Committee members only)

Click here for meeting documents 

The CTN Sessions are now Accredited

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Ottawa’s Office of Continuing Professional Development. You may claim a maximum of 7.5 hours (credits are automatically calculated).
 
La présente activité est une activité d’apprentissage collectif agréée (section 1), au sens que lui donne le programme de Maintien du certificat du Collège royal des médecins et chirurgiens du Canada; elle a été approuvée par le Bureau de formation professionnelle continue de l’Université d’Ottawa.Vous pouvez déclarer un maximum de 7,5 heures (les crédits sont calculés automatiquement).